DR. DAVID STEPHEN ZAMIEROWSKI, M.D.
Medical Practice at Lamar Ave, Overland Park, KS

2011027, Nov 3, 2011

Jul 12, 2011

13/181399

Stephen K. Bubb - Kansas City MO, US
David S. Zamierowski - Overland Park KS, US

A61M 1/00

604317

A tissue closure treatment system and method are provided with an external patient interface. A first fluid transfer component FTC. comprises a strip of porous material, such as rayon, with liquid wicking properties. FTC. can be placed directly on a suture line for transferring fluid exuded therethrough. An underdrape is placed over FTC. and includes a slot exposing a portion of same. FTC. comprises a suitable hydrophobic foam material, such as polyurethane ether, and is placed over the underdrape slot in communication with FTC.1. Negative pressure is applied to FTC. through a connecting fluid, transfer component FTC.. A negative pressure source can comprises a manual device or a power-operated suction device. The tissue closure method includes a manual operating mode using a manual suction device with an automatic shut off for discontinuing suction when a predetermined volume of fluid has been drained. An automatic operating mode utilizes a microprocessor, which can be preprogrammed to respond to various patient and operating conditions. The method proceeds through several phases with different components in place and different patient interface functions occurring, in each.

6936037, Aug 30, 2005

Apr 8, 2003

10/409225

Stephen K. Bubb - Kansas City MO, US
David S. Zamierowski - Overland Park KS, US

KCI Licensing, Inc. - San Antonio TX

A61M001/00, A61M027/00, A61H007/00

604327, 604541, 604543, 604268, 601 6

A tissue closure treatment system and method are provided with an external patient interface. A first fluid transfer component FTC. comprises a strip of porous material, such as rayon, with liquid wicking properties. FTC. can be placed directly on a suture line for transferring fluid exuded therethrough. An underdrape is placed over FTC. and includes a slot exposing a portion of same. FTC. comprises a suitable hydrophobic foam material, such as polyurethane ether, and is placed over the underdrape slot in communication with FTC. Negative pressure is applied to FTC. through a connecting fluid transfer component FTC. A negative pressure source can comprises a manual device or a power-operated suction device. The tissue closure method includes a manual operating mode using a manual suction device with an automatic shut off for discontinuing suction when a predetermined volume of fluid has been drained. An automatic operating mode utilizes a microprocessor, which can be preprogrammed to respond to various patient and operating conditions.

6951553, Oct 4, 2005

Dec 31, 2002

10/334766

Stephen K. Bubb - Kansas City MO, US
David S. Zamierowski - Overland Park KS, US

KCI Licensing, Inc - San Antonio TX

A61M001/00, A61M027/00, A61M007/00

604327, 604541, 604543, 604268, 601 6

A tissue closure treatment system and method are provided with an external patient interface. A first fluid transfer component FTC. comprises a strip of porous material, such as rayon, with liquid wicking properties. FTC. can be placed directly on a suture line for transferring fluid exuded therethrough. An underdrape is placed over FTC. and includes a slot exposing a portion of same. FTC. comprises a suitable hydrophobic foam material, such as polyurethane ether, and is placed over the underdrape slot in communication with FTC. Negative pressure is applied to FTC. through a connecting fluid transfer component FTC. A negative pressure source can comprises a manual device or a power-operated suction device. The tissue closure method includes a manual operating mode using a manual suction device with an automatic shut off for discontinuing suction when a predetermined volume of fluid has been drained. An automatic operating mode utilizes a microprocessor, which can be preprogrammed to respond to various patient and operating conditions.

7976519, Jul 12, 2011

Oct 3, 2005

11/242508

Stephen K. Bubb - Kansas City MO, US
David S. Zamierowski - Overland Park KS, US

KCI Licensing, Inc. - San Antonio TX

A61M 35/00

604289

A tissue closure treatment system and method are provided with an external patient interface. A first fluid transfer component (FTC) can be placed directly on a suture line for transferring fluid exuded therethrough. An underdrape is placed over FTC and includes a slot exposing a portion of same. A second fluid transfer component (FTC) is placed over the underdrape slot in communication with FTC. Negative pressure is applied to FTC through a connecting fluid transfer component (FTC). The tissue closure method includes a manual operating mode using a manual suction device with an automatic shut off for discontinuing suction when a predetermined volume of fluid has been drained. An automatic operating mode utilizes a microprocessor, which can be preprogrammed to respond to various patient and operating conditions. The method proceeds through several phases with different components in place and different patient interface functions occurring in each.

2013015, Jun 13, 2013

Dec 12, 2012

13/712872

David S. Zamierowski - Overland Park KS, US
Stephen K. Bubb - Kansas City MO, US
Wade M. Billings - Lawrence KS, US
Patrick A. Hildebrandt - Lenexa KS, US
Eric J. Tobaben - Lawrence KS, US

G06F 17/50

703 11

A description of a device and method of use are provided for a containment chamber, accompanying sensing and monitoring instrumentation, and method of creation of a physical force wave that would be capable of mimicking physiologic waves such as pulse pressure, muscle contraction, peristalsis, acoustic waves and other desired waves to be studied. This device allows for the use of various biologic or biologically comparable fluids—alone or in combination—that would allow for the analysis of the passage of these waves through these media. Singularly, this device also allows for the manipulation of the external constraints that mimic the containment of that media in vivo. This allows for the analysis of the effects on the nature of the wave, its reflections, potential augmentation or dampening that occur in conjunction with various selected external and internal (baffle) constraints that mimic those found in nature or in therapeutic interventions.

7108683, Sep 19, 2006

Apr 30, 2002

10/135741

David S. Zamierowski - Overland Park KS, US

KCI Licensing, Inc - San Antonio TX

A61F 13/00, A61F 13/02

604304, 604305, 604306, 604307, 604308

A wound therapy and tissue management system utilizes fluid differentiation. Fluid is differentiated by establishing a gradient within the system. A gradient can be established with matter or energy. Patient interfaces for establishing, maintaining and varying one or more gradients include transfer elements with first and second zones having different flow coefficients. The transfer elements exchange fluid with a patient, generally through a wound site, and with external components of the system. Osmotic solution gradients are controlled by a methodology involving the present invention for extracting solutions, which can include toxins, from patients and for introducing fluids and sumping air to wound sites.

2009010, Apr 23, 2009

Dec 31, 2007

11/968043

David S. Zamierowski - Overland Park KS, US
Kathy A. Carver - Overland Park KS, US

H04N 7/18

348143, 348E07085

An AV system and method for teleconferencing includes input and output subsystems. The input subsystem includes at least a pair of cameras and a microphone. The cameras can be mounted on a portable cart and adapted for repositioning in order to provide optimum camera spacing and angles to accommodate particular subject matter being covered. The input subsystem is connected to a controller, which can be connected to the Internet or some other network whereby systems at various sites can be linked for teleconferencing multiple participants, who can be either geographically remote from each other or located in close proximity. The output subsystem includes multi-screen displays, which are configured for simulating live participation by viewers. The display devices can be mounted on the cart, along with speakers for playing audio content.

7645269, Jan 12, 2010

Sep 19, 2006

11/523672

David S. Zamierowski - Overland Park KS, US

KCI Licensing, Inc. - San Antonio TX

A61F 13/00

604305, 604543

A wound therapy and tissue management system utilizes fluid differentiation. Fluid is differentiated by establishing a gradient within the system. A gradient can be established with matter or energy. Patient interfaces for establishing, maintaining and varying one or more gradients include transfer elements with first and second zones having different flow coefficients. The transfer elements exchange fluid with a patient, generally through a wound site, and with external components of the system. Osmotic solution gradients are controlled by a methodology involving the present invention for extracting solutions, which can include toxins, from patients and for introducing fluids and sumping air to wound sites.

7662112, Feb 16, 2010

May 13, 2005

11/129614

David S. Zamierowski - Overland Park KS, US
Robin S. Hursh - Lenexa KS, US

KCI Licensing, Inc. - San Antonio TX

A61B 5/103

600587

A subsurface wound measuring device and method are provided for measuring a subsurface wound or cavity of a patient, the device including a flexible strip having first and second sections, the sections having first and second ends respectively with an intermediate bend being located between the first and second ends. The first end is adapted for being located internally to a patient, the second end being adapted for being located externally to the patient. The first and second sections have generally concave-shaped cross-sections with measuring indicia being located along at least one of the sections. The device also optionally includes a measuring strip and a receiver mounted on the second end for receiving the measuring strip, where the measuring strip and the flexible strip form complementary structure for measuring a subsurface wound or cavity.

2012007, Mar 29, 2012

Sep 26, 2011

13/245677

David S. Zamierowski - Overland Park KS, US

A61F 2/02

623 2372

A system for in-vivo and ex-vivo tissue regeneration and cellular control, manipulation and management includes a source of cell manipulating factors, which are administered to a therapy zone via active pressure-differential components including a pump and a controller, or pulse-waves generated passively. A plate comprising tissue or an inert, bio-compatible material is provided in the therapy zone in proximity to a fluid flow manifold and tissue scaffolding. A tissue regeneration and cellular control method includes the steps of providing a cell manipulation factor source, providing one or more factors to a therapy zone and forming a pressure wave with a mechanical component or an in-vivo pressure wave source, such as the circulatory or lymphatic system.